Loading compare…
11 funds hold both · as on Jul 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 11 mutual funds hold active equity positions in both Orchid Pharma and Sun Pharmaceutical Industries. The scheme with the highest combined exposure is Kotak Healthcare Fund (Kotak MF), which holds a 1.88% stake in Orchid Pharma and a 14.88% stake in Sun Pharmaceutical Industries, amounting to a combined conviction weight of 16.76%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Orchid wt. | Sun wt. | Combined |
|---|---|---|---|
| Kotak Healthcare FundKotak MF · Sectoral / Thematic | 1.88% | 14.88% | |
| Nippon India Pharma FundNippon India MF · Sectoral / Thematic | 1.09% | 13.81% | |
| Back to IndexMotilal Oswal MF · Index Fund | 0.09% | 13.32% | |
| UTI - Healthcare FundUTI MF · Sectoral / Thematic | 0.73% | 8.71% | |
| Kotak MNC FundKotak MF · Sectoral / Thematic | 1.15% | 3.11% | |
| Kotak Special Opportunities FundKotak MF · Sectoral / Thematic | 2.85% | 0.61% | |
| Kotak Consumption FundKotak MF · Sectoral / Thematic | 1.60% | 1.13% | |
| UTI Value FundUTI MF · Value | 1.23% | 1.44% | |
| Kotak Multicap FundKotak MF · Multi Cap | 0.09% | 2.28% | |
| Kotak Balanced Advantage FundKotak MF · Hybrid | 0.01% | 0.78% | |
| UTI Conservative Hybrid FundUTI MF · Hybrid | 0.31% | 0.36% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on Jul 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.